Trump Administration Should Strengthen IP Protection to Counter Foreign Economic Exploitation
Source: "Foreign nations exploited US innovation for years — Trump is quietly hitting back | Fox News." March 20, 2026. www.foxnews.com
The Gist
The authors argue that foreign countries have been stealing or unfairly using American innovations for years, hurting our economy. They claim Trump's behind-the-scenes efforts to force other countries to respect our patents and pay fair prices for our inventions could help America more than his famous tariffs.
Conclusion
The Trump administration's efforts to strengthen intellectual property protections against foreign exploitation may prove more beneficial for American companies, workers, and consumers than its tariff policies
Premises
- Foreign governments have systematically weakened American firms' intellectual property protections and deprived them of overseas sales opportunities for decades
- IP-intensive industries support nearly half of U.S. GDP and more than 62 million jobs, making IP protection crucial to America's economy
- Foreign governments use abusive trade practices like price controls, mandatory rebates, and regulatory delays to artificially suppress spending on American-invented medicines
- The EU has adopted legislation cutting market exclusivity periods for new drugs and is considering rules to force companies to hand over patented technologies
- Mexico has failed to uphold IP commitments from the USMCA trade deal, allowing premature generic product launches without proper patent verification
- The administration has already achieved some success, such as the UK deal requiring doubled medicine spending in exchange for tariff exemptions
- The DOJ and PTO have taken steps to block patent-infringing imports and support injunctive relief for American companies
Assumptions
- Strong IP protections are necessary to incentivize innovation and research investment
- Foreign countries are deliberately exploiting American innovation rather than facing legitimate economic constraints
- American pharmaceutical and technology companies deserve stronger protection from foreign competition
- The current international IP framework is insufficient to protect American interests
- Economic nationalism in IP policy will benefit American workers and consumers overall